ClinicalTrials.Veeva

Menu

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

J

Jiangsu Provincial Center for Disease Control and Prevention

Status

Completed

Conditions

Parotid Gland Infection
Fever

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02901990
JSEPI001

Details and patient eligibility

About

This study was aimed to conduct a 3-year perspective study to observe the immunological effect of one-dose mumps-containing vaccine, monitor the incidence of mumps in vaccinated population aged 3-7 years,and provide basis for adjusting MMR immunization strategy in Jiangsu province, China.

Full description

in 3-7 years old children with high risk of mumps, epidemiological investigation of the serum IgG antibody level were conducted, and then a prospective observational cohort was established in the population with a history of mumps vaccination, and the incidence of mumps in each antibody level group will be observed, the relationship between different antibody levels and the incidence after mumps vaccinated were analyzed, to explore attenuation of mumps IgG antibody levels in the body,S79 vaccine strain against F genotype mumps' antigenic cross-reactivity and the protective effect of antibodies.

Enrollment

7,901 patients

Sex

All

Ages

3 to 7 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Children aged 3-7 years old;
  2. local resident children living at least 3 months;
  3. physical health, has been vaccinated at least once a dose of MuV

Exclusion criteria

  1. did not administer MuV;
  2. refused to collect venous blood;
  3. have been infected with mumps;
  4. have serious illness or other reasons should not participate in the study after clinical evaluation

Trial design

7,901 participants in 2 patient groups

GMT-low-level group
Description:
low geometric mean titer (GMT) detected in the children who had received one-dose mumps-containing vaccine from precious cross sectional study
GMT-high-level group
Description:
high geometric mean titer (GMT) detected in the children who had received one-dose mumps-containing vaccine from precious cross sectional study

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems